High-grade astrocytoma with piloid features

Changed by Ashesh Ishwarlal Ranchod, 5 Mar 2023
Disclosures - updated 19 Dec 2022: Nothing to disclose

Updates to Article Attributes

Body was changed:

High-grade astrocytoma with piloid features is a recently described rare tumour most commonly encountered in the posterior fossa of adults, especially those with neurofibromatosis type 1. It appears heterogeneous and has a dismal prognosis. 

Epidemiology

Due to the small number of patients so far reported, it is difficult to make strong pronouncements on the epidemiology of this tumour, however, cases so far appear to be primarily in middle-aged and elderly individuals 1,3. Neurofibromatosis type 1 appears to be an association 1

Pathology

This rare tumour was first included in the 5th Edition (2021) of the WHO classification of CNS tumours as a circumscribed astrocytic glioma 2

It is defined by a characteristic DNA-methylation profile

Location

The small number of tumours reported have occurred throughout the brain, brainstem and spinal cord with a predilection for the posterior fossa, and especially the cerebellum 1

Microscopic appearance

The histological appearance of these tumours is varied with reported cases having histological diagnoses of anaplastic pilocytic astrocytoma or glioblastoma 1.  

Molecular characteristics

Alterations are commonly encountered in 1

Radiographic features

MRI

Due to the small number of cases reported to date, specific or even suggestive imaging features are not yet evident especially as the tumours that have been described are heterogeneous in location (see above) and appearance 1

Generally, they appear to be peripherally enhancing lesions with high T2 signal but without diffusion restriction of either central or peripheral components 1

Treatment and prognosis

No tumour specific treatments are available at this time with treatment being empirical consisting of maximal safe surgical resection with concurrent chemoradiotherapy (e.g. temozolomide) 1

Prognosis is poor, similar to glioblastoma (IDH-wildtype) 1

  • -<p><strong>High-grade astrocytoma with piloid features</strong> is a recently described rare tumour most commonly encountered in the posterior fossa of adults, especially those with <a href="/articles/neurofibromatosis-type-1">neurofibromatosis type 1</a>. It appears heterogeneous and has a dismal prognosis. </p><h4>Epidemiology</h4><p>Due to the small number of patients so far reported, it is difficult to make strong pronouncements on the epidemiology of this tumour, however, cases so far appear to be primarily in middle-aged and elderly individuals <sup>1,3</sup>. Neurofibromatosis type 1 appears to be an association <sup>1</sup>. </p><h4>Pathology</h4><p>This rare tumour was first included in the 5th Edition (2021) of the <a href="/articles/who-classification-of-cns-tumours-1">WHO classification of CNS tumours</a> as a <a href="/articles/astrocytic-tumours">circumscribed astrocytic glioma</a> <sup>2</sup>. </p><p>It is defined by a characteristic <a title="DNA-methylation" href="/articles/dna-methylation">DNA-methylation profile</a>. </p><h5>Location</h5><p>The small number of tumours reported have occurred throughout the brain, brainstem and spinal cord with a predilection for the posterior fossa, and especially the cerebellum <sup>1</sup>. </p><h5>Microscopic appearance</h5><p>The histological appearance of these tumours is varied with reported cases having histological diagnoses of anaplastic pilocytic astrocytoma or glioblastoma <sup>1</sup>.  </p><h5>Molecular characteristics</h5><p>Alterations are commonly encountered in <sup>1</sup>: </p><ul>
  • -<li><a href="/articles/nf1-gene">NF1</a></li>
  • -<li><a href="/articles/braf-1">BRAF</a></li>
  • -<li><a href="/articles/fgfr1">FGFR1</a></li>
  • -<li><a href="/articles/cdkn2a-b-deletion">CDKN2A/B deletion</a></li>
  • -<li>
  • -<a href="/articles/alpha-thalassemiaintellectual-disability-syndrome-x-linked-atrx-gene-tumour-marker">ATRX</a> (mutations or loss)a</li>
  • -<li>
  • -<a href="/articles/methylguanine-dna-methyltransferase-mgmt">MGMT</a> promoter methylation</li>
  • +<p><strong>High-grade astrocytoma with piloid features</strong> is a recently described rare tumour most commonly encountered in the posterior fossa of adults, especially those with <a href="/articles/neurofibromatosis-type-1">neurofibromatosis type 1</a>. It appears heterogeneous and has a dismal prognosis. </p><h4>Epidemiology</h4><p>Due to the small number of patients so far reported, it is difficult to make strong pronouncements on the epidemiology of this tumour, however, cases so far appear to be primarily in middle-aged and elderly individuals <sup>1,3</sup>. Neurofibromatosis type 1 appears to be an association <sup>1</sup>. </p><h4>Pathology</h4><p>This rare tumour was first included in the 5th Edition (2021) of the <a href="/articles/who-classification-of-cns-tumours-1">WHO classification of CNS tumours</a> as a <a href="/articles/astrocytic-tumours">circumscribed astrocytic glioma</a> <sup>2</sup>. </p><p>It is defined by a characteristic <a title="DNA-methylation" href="/articles/dna-methylation">DNA-methylation profile</a>. </p><h5>Location</h5><p>The small number of tumours reported have occurred throughout the brain, brainstem and spinal cord with a predilection for the posterior fossa, and especially the cerebellum <sup>1</sup>. </p><h5>Microscopic appearance</h5><p>The histological appearance of these tumours is varied with reported cases having histological diagnoses of anaplastic pilocytic astrocytoma or glioblastoma <sup>1</sup>.  </p><h5>Molecular characteristics</h5><p>Alterations are commonly encountered in <sup>1</sup>: </p><ul>
  • +<li><a href="/articles/nf1-gene">NF1</a></li>
  • +<li><a href="/articles/braf-1">BRAF</a></li>
  • +<li><a href="/articles/fgfr1">FGFR1</a></li>
  • +<li><a href="/articles/cdkn2a-b-deletion">CDKN2A/B deletion</a></li>
  • +<li>
  • +<a href="/articles/alpha-thalassemia-intellectual-disability-syndrome-x-linked-atrx-gene-tumour-marker">ATRX</a> (mutations or loss)a</li>
  • +<li>
  • +<a href="/articles/methylguanine-dna-methyltransferase-mgmt">MGMT</a> promoter methylation</li>
Images Changes:

Image 1 MRI (T1 C+) ( create )

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.